Press Releases: National
March 26, 2008
Kaiser Permanente Study Shows That a Larger Abdomen in Midlife Increases Risk of Dementia
Overweight and obese individuals with large bellies have double or triple the risk of dementia
OAKLAND, Calif. – People in their 40s with larger stomachs have a higher risk for dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Previous studies have looked at central obesity (as determined by waist circumference) and body mass index in the elderly and its link to dementia risk. In addition, previous studies have shown that a large abdomen -- in midlife -- increases the risk of diabetes, stroke, and coronary heart disease. This is the first time researchers have demonstrated a longitudinal association between midlife belly fat and the risk of dementia.
Capturing abdominal obesity in midlife may be a much better indicator of the long-term metabolic dysregulation that leads to dementia risk, said study author Rachel Whitmer, Ph.D., a research scientist at the Kaiser Permanente Division of Research in Oakland, Calif. Measuring abdomen size in older age people may not be as good an indicator because as people age they tend to naturally lose muscle and bone mass and gain belly size, she explained.
“Considering that 50 percent of adults in this country have abdominal obesity, this is a disturbing finding. It is well known that being overweight in midlife and beyond increases risk factors for disease. However, where one carries the weight –especially in midlife -- appears to be an important predictor for dementia risk,” she said.
“Autopsies have shown that changes in the brain associated with Alzheimer’s disease may start in young to middle adulthood, and another study showed that high abdominal fat in elderly adults was tied to greater brain atrophy. These findings imply that the dangerous effects of abdominal obesity on the brain may start long before the signs of dementia appear.” She explained that additional research needs to be completed to determine the underlying mechanisms that link abdominal obesity in midlife to dementia risk.
Researchers studied 6,583 people ages 40 to 45 in Northern California who had their abdominal density measured. Belly fat was measured by using a caliper to determine the distance from the back to the upper abdomen, midway between the top of the pelvis and the bottom of the ribs. Belly density is highly correlated with visceral fat tissue, the fat tissue that is wrapped around the organs, according to the researchers. An average of 36 years later, 16 percent of the participants had been diagnosed with dementia.
The study found that those who were overweight and had a large belly were 2.3 times more likely to develop dementia than people with a normal weight and belly size. People who were both obese and had a large belly were 3.6 times more likely to develop dementia than those of normal weight and belly size. Those who were overweight or obese but did not have a large abdomen had an 80 percent increased risk of dementia.
Having a large abdomen increased the risk of dementia regardless of whether the participants were of normal weight overall, overweight, or obese, and regardless of existing health conditions, including diabetes, stroke and cardiovascular disease.
Non-whites, smokers, people with high blood pressure, high cholesterol or diabetes, and those with less than a high school level of education were more likely to have abdominal obesity.
As with all observational studies, it is possible that the association of the abdominal obesity and dementia is not driven by the abdominal obesity, but rather by a complex set of health-related behaviors, for which abdominal obesity is but one part.
Additional authors on the study include Deborah R. Gustafson, Ph.D., Goteberg University, Goteberg, Sweden; Elizabeth Barrett-Connor, MD, department of family medicine, University of California, La Jolla, Calif.; Mary N. Haan, DrPH, department of epidemiology, University of Michigan, Ann Arbor, Mich.; Erica P. Gunderson, Ph.D., Kaiser Permanente Division of Research, Oakland, Calif.; and Kristine Yaffe, MD, Departments of Psychiatry, Neurology and Epidemiology, University of California, San Francisco. Funding for the study was provided by the National Institutes of Health.
The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and multiple sclerosis.
For more information about the American Academy of Neurology, visit www.aan.com.
About Kaiser Permanente
Kaiser Permanente is America's leading integrated health plan. Founded in 1945, it is a not-for-profit; group practice prepayment program headquartered in Oakland, Calif. Kaiser Permanente serves the health care needs of 8.7 million members in nine states and the District of Columbia. Today it encompasses the not-for-profit Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and their subsidiaries, and the for-profit Permanente Medical Groups. Nationwide, Kaiser Permanente includes approximately 159,000 technical, administrative and clerical employees and caregivers, and more than 13, 000 physicians representing all specialties. For more Kaiser Permanente news, visit the KP News Center, : http://xnet.kp.org/newscenter.
About Kaiser Permanente Research
Kaiser Permanente's eight research centers comprise one of the largest research programs in the U.S. and engage in work designed to improve the health of individuals everywhere. KP HealthConnect™ , Kaiser Permanente’s electronic health record, and other resources provide population data for research, and in turn, research findings arm KP physicians with up-to-the-minute research and clinical data. Kaiser Permanente's research program works with national and local health agencies and community organizations to share and widely disseminate its research data. Kaiser Permanente’s research program is funded in part by Kaiser Permanente’s Community Benefit division, which in 2006 directed $808 million in health services, technology, and funding toward total community health.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 8.6 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.